Aperio Technologies Inc., a Vista, Calif.-based provider of digital pathology services for the healthcare and life sciences industry, has raised $20 million in Series C funding. HLM Venture Partners led the round, and was joined by Acadia Woods Partners, BlackRock Alternative Advisors and return backers Galen Partners and Advanced Technology Ventures. It had previously raised around $27 million.
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, is pleased to announce the completion of a $20 million Series C financing. The round was led by HLM Venture Partners, a Boston and San Francisco-based healthcare venture capital firm. Joining HLM in the Series C funding are existing investors Galen Partners and Advanced Technology Ventures, and new investors Acadia Woods Partners and BlackRock Alternative Advisors.
Aperio will use the new capital to accelerate clinical market development, expand sales and operations, and develop new products in support of its patented digital pathology system, which includes its linear array-based ScanScope